Cargando…

Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial

Aim: To determine if supplementation of infants born <33 weeks’ gestation with higher dose docosahexaenoic acid (DHA) affects growth, body composition, and blood pressure at 7 y corrected age (CA) and if treatment effects differed by infant sex at birth and birth weight strata (<1250 and ≥1250...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, Karen P., Sullivan, Thomas R., Gunaratne, Anoja W., Gould, Jacqueline F., Gibson, Robert A., Collins, Carmel T., Makrides, Maria, Green, Tim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867194/
https://www.ncbi.nlm.nih.gov/pubmed/36678206
http://dx.doi.org/10.3390/nu15020335
_version_ 1784876281826902016
author Best, Karen P.
Sullivan, Thomas R.
Gunaratne, Anoja W.
Gould, Jacqueline F.
Gibson, Robert A.
Collins, Carmel T.
Makrides, Maria
Green, Tim J.
author_facet Best, Karen P.
Sullivan, Thomas R.
Gunaratne, Anoja W.
Gould, Jacqueline F.
Gibson, Robert A.
Collins, Carmel T.
Makrides, Maria
Green, Tim J.
author_sort Best, Karen P.
collection PubMed
description Aim: To determine if supplementation of infants born <33 weeks’ gestation with higher dose docosahexaenoic acid (DHA) affects growth, body composition, and blood pressure at 7 y corrected age (CA) and if treatment effects differed by infant sex at birth and birth weight strata (<1250 and ≥1250 g). Methods: Seven-year follow-up of an Australian multicenter randomized controlled trial in which 657 infants were fed high-DHA (≈1% total fatty acids) enteral feeds or standard-DHA (≈0.3% total fatty acids) from age 2–4 d until term CA. Seven-year CA outcomes were growth (weight, height), body composition (lean body mass, fat mass, waist, and hip circumference), and blood pressure. Results: There was no effect of high-DHA enteral feeds compared with standard-DHA on growth, body composition, and blood pressure at 7-year CA either overall or in subgroup analysis by sex. There was a significant interaction between high-DHA and birthweight strata on height at 7-y CA (p = 0.03). However, the post-hoc analyses by birthweight strata did not reach significance (p > 0.1). High-DHA group infants were more likely to be classified as obese (relative risk 1.6 (95% CI 1.0, 2.6); p = 0.05). Conclusions: DHA supplementation of premature infants did not affect growth, body composition, or blood pressure at 7-year CA overall by sex and birthweight strata. The finding of a higher risk of obesity in children who receive high-DHA needs to be interpreted with caution due to the small number of children classified as obese.
format Online
Article
Text
id pubmed-9867194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98671942023-01-22 Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial Best, Karen P. Sullivan, Thomas R. Gunaratne, Anoja W. Gould, Jacqueline F. Gibson, Robert A. Collins, Carmel T. Makrides, Maria Green, Tim J. Nutrients Article Aim: To determine if supplementation of infants born <33 weeks’ gestation with higher dose docosahexaenoic acid (DHA) affects growth, body composition, and blood pressure at 7 y corrected age (CA) and if treatment effects differed by infant sex at birth and birth weight strata (<1250 and ≥1250 g). Methods: Seven-year follow-up of an Australian multicenter randomized controlled trial in which 657 infants were fed high-DHA (≈1% total fatty acids) enteral feeds or standard-DHA (≈0.3% total fatty acids) from age 2–4 d until term CA. Seven-year CA outcomes were growth (weight, height), body composition (lean body mass, fat mass, waist, and hip circumference), and blood pressure. Results: There was no effect of high-DHA enteral feeds compared with standard-DHA on growth, body composition, and blood pressure at 7-year CA either overall or in subgroup analysis by sex. There was a significant interaction between high-DHA and birthweight strata on height at 7-y CA (p = 0.03). However, the post-hoc analyses by birthweight strata did not reach significance (p > 0.1). High-DHA group infants were more likely to be classified as obese (relative risk 1.6 (95% CI 1.0, 2.6); p = 0.05). Conclusions: DHA supplementation of premature infants did not affect growth, body composition, or blood pressure at 7-year CA overall by sex and birthweight strata. The finding of a higher risk of obesity in children who receive high-DHA needs to be interpreted with caution due to the small number of children classified as obese. MDPI 2023-01-10 /pmc/articles/PMC9867194/ /pubmed/36678206 http://dx.doi.org/10.3390/nu15020335 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Best, Karen P.
Sullivan, Thomas R.
Gunaratne, Anoja W.
Gould, Jacqueline F.
Gibson, Robert A.
Collins, Carmel T.
Makrides, Maria
Green, Tim J.
Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
title Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
title_full Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
title_fullStr Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
title_full_unstemmed Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
title_short Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
title_sort effect of docosahexaenoic acid (dha) supplementation of preterm infants on growth, body composition, and blood pressure at 7-years corrected age: follow-up of a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867194/
https://www.ncbi.nlm.nih.gov/pubmed/36678206
http://dx.doi.org/10.3390/nu15020335
work_keys_str_mv AT bestkarenp effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT sullivanthomasr effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT gunaratneanojaw effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT gouldjacquelinef effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT gibsonroberta effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT collinscarmelt effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT makridesmaria effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial
AT greentimj effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial